Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PER2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PER2 is a protein involved in neurodegeneration research. Key relationships include: expressed in, regulates, activates. Associated with Als, Alzheimer, Autism. Connected to 106 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | Period Circadian Regulator 2 |
| Chromosome | 2p13 |
| Function | PER2 is a core clock gene essential for circadian rhythm generation. |
| Molecular Weight | 180 kDa |
| Pathways | Akt, Circadian Rhythm, Lipid Metabolism, Mtor, Pi3K |
| UniProt ID | Q8BZD0 |
| NCBI Gene ID | 8864 |
| Ensembl ID | ENSG00000132266 |
| OMIM | 603714 |
| Associated Diseases | ALS, autism spectrum disorder, Ms |
| Interactions | AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID, AND, APP |
| KG Connections | 200 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
PER2["PER2"]
PER2 -->|"regulates"| Als["Als"]
PER2 -->|"activates"| Ms["Ms"]
PER2 -->|"regulates"| Autism["Autism"]
PER2 -->|"expressed in"| Carcinoma["Carcinoma"]
PER2 -->|"expressed in"| Cancer["Cancer"]
PER2 -->|"expressed in"| Tumor["Tumor"]
CRY1["CRY1"] -->|"interacts"| PER2
BMAL1["BMAL1"] -->|"interacts"| PER2
CLOCK["CLOCK"] -->|"interacts"| PER2
GENES["GENES"] -->|"regulates"| PER2
PER1["PER1"] -->|"expressed in"| PER2
AKT["AKT"] -->|"expressed in"| PER2
MTOR["MTOR"] -->|"regulates"| PER2
FASN["FASN"] -->|"regulates"| PER2| Target | Relation | Type | Str |
|---|---|---|---|
| PD-L1 | inhibits | protein | 0.95 |
| NF-κB | inhibits | pathway | 0.95 |
| HSP90 | binds_to | protein | 0.92 |
| oral squamous cell carcinoma | protects_against | disease | 0.88 |
| IKK | promotes | protein | 0.88 |
| Circadian Rhythm | expressed_in | pathway | 0.80 |
| circadian regulation | participates_in | pathway | 0.75 |
| Sleep Disorder | expressed_in | disease | 0.65 |
| Carcinoma | expressed_in | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Schizophrenia | expressed_in | disease | 0.65 |
| Autism | expressed_in | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Ataxia | expressed_in | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Rheumatoid Arthritis | therapeutic_target | disease | 0.65 |
| Autism | regulates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| AKT | expressed_in | gene | 0.60 |
| MTOR | expressed_in | gene | 0.60 |
| PER3 | expressed_in | gene | 0.60 |
| PER1 | associated_with | gene | 0.60 |
| NR1D1 | expressed_in | gene | 0.60 |
| MTNR1B | associated_with | gene | 0.60 |
| ARNTL | expressed_in | gene | 0.60 |
| Akt | activates | pathway | 0.60 |
| AMYLOID | expressed_in | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| AMYLOID-BETA | expressed_in | gene | 0.60 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.60 |
| CIRCADIAN RHYTHM | expressed_in | gene | 0.60 |
| Mtor | expressed_in | pathway | 0.60 |
| Pi3K/Akt | expressed_in | pathway | 0.60 |
| autism spectrum disorder | interacts_with | disease | 0.60 |
| autism spectrum disorder | associated_with | disease | 0.60 |
| APP | expressed_in | gene | 0.60 |
| Mtor | activates | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-de52344d | targets_gene | hypothesis | 0.90 |
| PER1 | expressed_in | gene | 0.70 |
| CRY1 | expressed_in | gene | 0.70 |
| CRY2 | expressed_in | gene | 0.70 |
| CRY1 | activates | gene | 0.65 |
| CLOCK | interacts_with | gene | 0.60 |
| CLOCK | regulates | gene | 0.60 |
| BMAL1 | regulates | gene | 0.60 |
| PER3 | expressed_in | gene | 0.60 |
| MTNR1A | associated_with | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| BMAL1 | interacts_with | gene | 0.60 |
| MTNR1B | interacts_with | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| APP | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| CRY2 | interacts_with | gene | 0.60 |
| APP/PS1 | expressed_in | gene | 0.60 |
| CRY1 | interacts_with | gene | 0.60 |
| CRY2 | regulates | gene | 0.60 |
| MTOR | regulates | gene | 0.60 |
| FASN | regulates | gene | 0.60 |
| CRY1 | regulates | gene | 0.60 |
| AKT | regulates | gene | 0.60 |
| NAMPT | regulates | gene | 0.60 |
| UBIQUITIN | regulates | gene | 0.60 |
| UBR5 | inhibits | gene | 0.60 |
| FASN | expressed_in | gene | 0.60 |
| NFKBIA | expressed_in | gene | 0.60 |
| PGC1A | expressed_in | gene | 0.60 |
| PER3 | associated_with | gene | 0.60 |
| PER1 | associated_with | gene | 0.60 |
| CRY1 | associated_with | gene | 0.60 |
| NPAS2 | associated_with | gene | 0.60 |
| CRY2 | associated_with | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| SLC31A1 | activates | gene | 0.60 |
| BMAL1 | expressed_in | gene | 0.60 |
| CLOCK | expressed_in | gene | 0.60 |
| PI3K | expressed_in | gene | 0.60 |
| PER1 | regulates | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| CLOCK | activates | gene | 0.60 |
| ARNTL | expressed_in | gene | 0.60 |
| MTNR1B | associated_with | gene | 0.60 |
| NR1D1 | expressed_in | gene | 0.60 |
| AMYLOID-BETA | expressed_in | gene | 0.60 |
| AMYLOID | expressed_in | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning PER2 in their description or question text
No additional research found